VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,412,627 | -34.8% | 326,997 | -0.5% | 1.00% | -29.0% |
Q2 2023 | $2,165,922 | -4.2% | 328,668 | -1.3% | 1.41% | -5.7% |
Q1 2023 | $2,260,140 | -8.7% | 332,863 | -0.6% | 1.49% | -14.2% |
Q4 2022 | $2,475,310 | -25.2% | 334,954 | 0.0% | 1.74% | -31.3% |
Q3 2022 | $3,309,000 | +7.7% | 334,954 | +18.8% | 2.53% | +12.3% |
Q2 2022 | $3,071,000 | -3.7% | 281,890 | 0.0% | 2.26% | +14.5% |
Q1 2022 | $3,190,000 | -14.6% | 281,890 | +18.4% | 1.97% | -16.1% |
Q4 2021 | $3,735,000 | +178.9% | 238,060 | +204.6% | 2.35% | +152.3% |
Q3 2021 | $1,339,000 | -75.7% | 78,154 | -69.5% | 0.93% | -68.1% |
Q2 2021 | $5,519,000 | +43.2% | 256,546 | 0.0% | 2.92% | +33.0% |
Q1 2021 | $3,853,000 | +12.0% | 256,546 | -2.0% | 2.19% | -0.5% |
Q4 2020 | $3,441,000 | +36.1% | 261,891 | 0.0% | 2.21% | +41.1% |
Q3 2020 | $2,529,000 | +15.7% | 261,891 | +37.1% | 1.56% | +2.4% |
Q2 2020 | $2,185,000 | +100.5% | 190,990 | +81.5% | 1.53% | +49.6% |
Q1 2020 | $1,090,000 | – | 105,234 | – | 1.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |